Email Address / User Name:
Password:
:Remember Login



Register Here!



Our Services



Naked Short List

by Date

by Exchange



Our Press Releases



SEC & Other Articles




Symbol :

Listed 3 Consecutive Market Days. On List as of 01/23/2012 Through 01/26/2012

Current Quote*

Last: $6.250
Volume: 4,423,794

As Of: 2014-04-17 23:45:00 ET
*Quotes delayed by 20min.

Mannkind Corp (NASDAQ:MNKD)
Industry: Healthcare

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.


Realtime Data


BuyIns.Net Releases for Symbol MNKD



3 Month

6 Month

1 Year